This study included a considerable amount of autopsy-confirmed FTLD-Tau cases and several patients harboring C9orf72 mutation or with FTLD-ALS, which were not analyzed in our previous study. This evidence concerns the gene MAPT and amyotrophic lateral sclerosis.